Last Thursday’s Special Ethics Seminar at St Cross College was booked out very quickly, and the audience’s high expectations were fully justified. Rebecca Roache returned from Royal Holloway to Oxford to give a fascinating lecture on the nature and ethics of swearing. Roache has two initial questions: ‘Is there anything wrong with this fucking question?’, and ‘Is this one any f***ing better?’. (Her answers turn out to be, essentially, ‘No’ to both.) Continue reading
Fixed Odd Betting Terminals (FOBTs) allow punters to bet up to £100 a time in casino games such as roulette. Bookmakers are allowed four terminals in each shop, and there are now around 35,000 of them in the UK. In the latest version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) gambling disorder is described in the chapter on substance-disorder and related disorders. It was recently reported that industry-funded research showed that levels of ‘problem gambling’ among those using these machines ran at around 23%. Continue reading
We are delighted that Christine Korsgaard, Arthur Kingsley Porter Professor of Philosophy at Harvard University, has accepted our invitation to deliver the Uehiro Lectures in Oxford. The title of the series is Fellow Creatures, and this first fascinating and suggestive lecture – delivered on 1 December 2014 — is called ‘Animals, Human Beings, and Persons’. One primary purpose of this lecture is to clarify the similarities and differences between those three kinds of creature, and to clear the ground of some misunderstandings. Continue reading
Imagine that you have been left a large legacy, and would like to donate it to a charity, with a view to doing the most good possible.
It’s natural to think that one set of charities you should consider are those which cheaply save people’s lives, and perhaps particularly young people’s lives. For then you can count the good in the rest of those people’s lives as a good you’ve brought about. Continue reading
The Genetic Epidemiology of Psychiatric and Substance Abuse Disorders: Multiple Levels, Interactions and Causal Loops
What causes psychiatric disorders, such as depression or alcohol abuse disorders? It’s obvious that background and upbringing often play a significant role, as do life events, such as losing one’s spouse or one’s job. And we also know now that genetic propensities are important. But how do these different factors inter-relate with one another? For over three decades, these issues have been at the centre of the research of Oxford’s first Loebel Lecturer, Professor Kenneth Kendler.
Professor Kendler is one of the world’s leading, and most highly cited, psychiatric researchers. He uses a range of methods, including family studies, twin and adoption studies, and molecular genetics. He also has a serious interest in the philosophy of psychiatry. His first Loebel Lecture — The Genetic Epidemiology of Psychiatric and Substance Abuse Disorders: Multiple Levels, Interactions and Causal Loops – was presented at the Oxford Martin School on Wednesday 15 October 2014, and is now available on Youtube and as an MP3 audio file. Continue reading
Last week I attended part of a fascinating conference on Trust, organized by the Blavatnik School of Government in Oxford. In her opening paper, Katherine Hawley raised many interesting questions, including those of whether trustworthiness is a virtue and whether it can be a virtue of institutions. Continue reading
Tomorrow in the House of Lords Lord Falconer’s bill on assisted dying will be debated. The bill would allow those who are terminally ill and likely to die within six months to request life-ending drugs from their doctor for the patients to use as and when they see fit.
As might have been expected, there has been huge discussion over the bill, but most of the arguments presented so far are not new, and the same will probably be true tomorrow. But there is one I haven’t seen before, put forward recently by Giles Fraser: that assisted suicide is the ‘final triumph of market capitalism’. Continue reading
The use of placebos in medicine raises a large number of serious ethical issues. Do they involve deceiving patients, or violating their autonomy in some way? Are they harmful to certain patients, in research trials where the actual treatment being trialled is thought likely to be successful? Can placebos – if medically warranted – be funded through a health care budget? All these questions require us to be able to say what a placebo is, and that is more tricky than one might think. Continue reading